Schedule 13G ownership disclosure

Y-MABS THERAPEUTICS INC

Security class unavailable · CUSIP: 984241109

Event date: 2024-03-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-044794
Form type
SC 13G
Filer
Paradigm Biocapital Advisors LP
CIK
CIK 1855655
Filed
Apr 08, 2024
Reporting period
Mar 27, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub